Indications and uses
For the temporary relief of itchy eyes due to ragweed, pollen, grass, animal hair and dander.
For the temporary relief of itchy eyes due to ragweed, pollen, grass, animal hair and dander.
Adults and children 3 years and older: put 1 drop in the affected eye(s) twice daily, every 8-12 hours, no more than twice per day. Children under 3 years of age: consult a doctor
Ketotifen 0.025%
(equivalent to ketotifen fumarate 0.035%)
Antihistamine
For the temporary relief of itchy eyes due to ragweed, pollen, grass, animal hair and dander.
For external use only
Do not use
If swallowed, get medical help or contact a Poison Control Center right away.
Adults and children 3 years and older: put 1 drop in the affected eye(s) twice daily, every 8-12 hours, no more than twice per day.
Children under 3 years of age: consult a doctor
Store at 4-25°C (39-77°F)
benzalkonium chloride, 0.01%, glycerin, hydrochloric acid and/or sodium hydroxide, water for injection
Toll Free Product Information Call: 1-800-553-5340

NDC 24208-901-99
BONUS 1ML TRAVEL SIZE
BAUSCH + LOMB
Alaway®
ketotifen fumarate ophthalmic solution 0.035%
ANTIHISTAMINE EYE DROPS
UP TO
12
HOURS
EYE ITCH RELIEF
WORKS IN MINUTES!
▪ Original Prescription Strength
▪ For ages 3 years and older
[image – 1 mL Bottle]
[image – 10 mL Bottle]
STERILE 0.34 FL OZ (10 mL)+
0.03 FL OZ (1 mL)
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| KETOTIFEN FUMARATE | ACTIVE INGREDIENT | HBD503WORO | 3 | |
| KETOTIFEN | ACTIVE MOIETY | X49220T18G | 3 | |
| BENZALKONIUM CHLORIDE | INACTIVE INGREDIENT | F5UM2KM3W7 | 3 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 3 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | 3 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 24208-901 | 24208-901-99 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| KETOTIFEN FUMARATE | HBD503WORO | ACTIM |
| GLYCERIN | PDC6A3C0OX | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| HYDROCHLORIC ACID | QTT17582CB | IACT |
| WATER | 059QF0KO0R | IACT |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| KETOTIFEN FUMARATE | HBD503WORO | ACTIM |
| GLYCERIN | PDC6A3C0OX | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| HYDROCHLORIC ACID | QTT17582CB | IACT |
| WATER | 059QF0KO0R | IACT |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INTRATHECAL | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SOLUTION / SUBARACHNOID | ADJ PH | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION/ DROPS / AURICULAR (OTIC) | 0 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRA-AMNIOTIC | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRATHECAL | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE, LIQUID FILLED / ORAL | 1.5 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 78.36 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION / INTRASYNOVIAL | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SPONGE / TOPICAL | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION / EXTRACORPOREAL | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | GEL / TOPICAL | 10 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION / EPIDURAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | DISC / TOPICAL | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION / OPHTHALMIC | 0.31 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | TABLET, EXTENDED RELEASE / ORAL | 13 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SUSPENSION / ORAL | 100 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION/ DROPS / AURICULAR (OTIC) | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INTRAVITREAL | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SUSPENSION / INTRASYNOVIAL | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SOLUTION / INTRAVENOUS | 1037 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | GRANULE, FOR SUSPENSION / ORAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | TABLET, ORALLY DISINTEGRATING / ORAL | 1 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | GEL, METERED / TOPICAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRASPINAL | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INTERSTITIAL | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION / DENTAL | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | FILM, SOLUBLE / ORAL | 11 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / SUBCUTANEOUS | 1 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION / ORAL | 400 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SOLUTION / INTRATHECAL | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION / URETERAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRATHECAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION / OPHTHALMIC | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | LOTION / TOPICAL | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION / NASAL | 91.7 mg/100ml | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SUSPENSION / INTRAMUSCULAR | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, POWDER, FOR SOLUTION / INTRATUMOR | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / EXTRACORPOREAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION/ DROPS / TOPICAL | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SUSPENSION / AURICULAR (OTIC) | 0.04 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / EPIDURAL | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | TABLET / ORAL | 2.32 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | LIQUID / ORAL | 4.46 mg/1ml | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION / INTRACAUDAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CREAM / VAGINAL | 0.19 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / PERIODONTAL | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION / SUBCUTANEOUS | ADJ PH | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION, CONCENTRATE / INTRAVENOUS | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | ENEMA / RECTAL | 0.44 %v/v |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021996-001 | ALAWAY | KETOTIFEN FUMARATE | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | |
| N021996-002 | CHILDREN'S ALAWAY | KETOTIFEN FUMARATE | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021996-002 | CHILDREN'S ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021996-001 | ALAWAY | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2006-12-01 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021996-002 | ALAWAY | EQ 0.035% BASE | SOLUTION/DROPS / OPHTHALMIC | RLD | 2015-02-11 | 4b0b4de00fa7… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 9e5875e8-5082-4d6a-b28c-69b9d2bc6a57 | e99c2689-2408-4ab5-b8ff-406d8ed650e4 | 2018-12-03 | Warnings | 9e5875e8-5082-4d6a-b28c-69b9d2bc6a57 e99c2689-2408-4ab5-b8ff-406d8ed650e4 |
Adverse event summaries are temporarily unavailable. Other product information remains available.